New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
14:59 EDTBMY
theflyonthewall.com: FDA approves supplemental new drug application for Bristol-Myers's Abilify
Bristol-Myers Squibb and Otsuka Pharmaceutical announced that the FDA has approved the supplemental New Drug Application for ABILIFY for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods. :theflyonthewall.com



News For BMY From The Last 14 Days
Check below for free stories on BMY the last two weeks.
There are 15 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2010
12:01 EDTBMY
theflyonthewall.com: Gilead to start talks on quad pill partnership, Bloomberg reports
Gilead will start talks as soon as next week with Bristol-Myers Squibb (BMY) or Johnson & Johnson (JNJ) regarding a partnership for the company's four-drug combination AIDS pill, Gilead COO John Milligan said in an interview, according to Bloomberg. Milligan says Gilead was approached by a company about a partnership, but did not mention a company name. :theflyonthewall.com

February 8, 2010
09:30 EDTBMY
theflyonthewall.com: Bristol-Myers and KineMed broaden collaboration

Subscribe for More Information
:theflyonthewall.com

February 5, 2010
06:44 EDTBMY
theflyonthewall.com: Drug companies facing uncertainty as health reform stalls, NY Times reports

Subscribe for More Information
:theflyonthewall.com

February 4, 2010
07:11 EDTBMY
theflyonthewall.com: Pfizer to reduce R&D as it absorbs Wyeth, WSJ reports
Pfizer (PFE) plans to cut its R&D spending by up to $3B by 2012, which was more than 25% of the combined R&D of Pfizer and newly acquired Wyeth in 2008, reports the Wall Street Journal. The move is based on efficiencies without hurting future product development. Reference Link :theflyonthewall.com
07:03 EDTBMY
theflyonthewall.com: Bristol-Myers to freeze salaries in 2010, WSJ reports
Bristol-Myers Squibb (BMY), in a rare move in the pharmaceutical industry, will freeze employee salaries for the year, reports the Wall Street Journal. A spokeswoman said the freeze won't affect bonuses. Reference Link :theflyonthewall.com
06:59 EDTBMY
theflyonthewall.com: On The Fly: Periodicals Wrap-Up

Subscribe for More Information
:theflyonthewall.com

February 3, 2010
09:53 EDTBMY
theflyonthewall.com: Leerink hosts an analyst Biotechnology/Industry conference call

Subscribe for More Information
:theflyonthewall.com

January 29, 2010
13:29 EDTBMY
theflyonthewall.com: FDA alerts healthcare professionals about Bristol-Myers HIV drug

Subscribe for More Information
:theflyonthewall.com
13:26 EDTBMY
theflyonthewall.com: Bristol-Myers HIV drug Videx linked to rare liver risks, FDA says
Reported by Bloomberg. :theflyonthewall.com

January 28, 2010
12:10 EDTBMY
theflyonthewall.com: Bristol-Myers CEO: We are not for sale, Dow Jones reports
:theflyonthewall.com
07:46 EDTBMY
theflyonthewall.com: Bristol-Myers, Eli Lilly restructured collaboration agreement

Subscribe for More Information
:theflyonthewall.com
07:42 EDTBMY
theflyonthewall.com: Bristol-Myers sees FY10 EPS $2.15-$2.25 vs. consensus of $2.19
:theflyonthewall.com
07:41 EDTBMY
theflyonthewall.com: Bristol-Myers reports Q4 EPS 47c vs. consensus of 42c

Subscribe for More Information
:theflyonthewall.com
07:40 EDTBMY
theflyonthewall.com: Bristol-Myers reports Q4 EPS 47c

Subscribe for More Information
:theflyonthewall.com

January 27, 2010
16:43 EDTBMY
theflyonthewall.com: On The Fly: U.S. Market Wrap-Up for Wednesday 1/27
The markets opened slightly lower but quickly advanced into positive territory. The move, however, was short-lived. After a disappointing new home sales report brought out the sellers, the markets drifted lower. Once they crossed back into negative territory, the selling accelerated until each of the major indices was lower by at least 0.50%. The averages sat in a narrow range until the release of the FOMC rate decision. The knee jerk reaction was to sell on the news, but the averages quickly reversed and pushed into positive territory by the close…The Dow rose 41.87 to 10,236.16, the S&P gained 5.33 to 1,097.50, and the Nasdaq added 17.68 to 2,221.41…Among the biggest gainers: Sanmina-SCI Corp. (SANM) surged 15% to $14.15 after beating Q1 EPS estimates by a wide margin. Super Micro Computer (SMCI) soared 16.3% to $13.50 after forecasting better-than-expected Q3 EPS estimates…The losers included: Caterpillar (CAT) which slumped 4.3% to $53.44 after reporting Q4 earnings that fell 65%. The company also issued a disappointing FY10 forecast. Jackson Hewitt (JTX) dropped 16.5% to 2.94 after reporting that it does not believe it can finance its refund anticipation loans…CURRENCY: The dollar closed 0.36% higher on the yen at 89.93 and 0.41% lower on the euro at 0.7132…COMMODITIES: Crude oil closed down 1.05 to 73.66...Natural gas lost 0.19 to 5.24...Gold was lower by 13.00 to 1,086.50…ECONOMIC DATA: New Home Sales for December fell 7.6% to an annual sales rate of 342K versus a consensus range of 350K to 385K. MBA Purchase Applications for the week of 1/22 fell 3.3%. Crude Inventories for the week of January 22 were down -3.88M vs. consensus of 1.5M build. Gasoline inventories 1.99M vs. consensus of 900K build. Distillates 358K vs. consensus of 1.8M draw. The FOMC left interest rates unchanged between 0%-0.25% and expects rates to remain low for “an extended period.” They also said that MBS purchases will end in March as scheduled. Tomorrow…Durable Goods Orders, Jobless Claims, and EIA Natural Gas Report are due…Notable companies reporting Thursday before the opening bell include: Altria Group (MO), AT&T (T), Ball Corporation (BLL), Becton Dickinson and Company (BDX), Bemis (BMS), Bristol-Myers Squibb (BMY), Cardinal Health (CAH), Celgene (CELG), Consol Energy (CNX), Dominion Resources (D), Eastman Kodak (EK), EQT Corporation (EQT), Ford (F), Franklin Resources (BEN), Goodrich (GR), Invesco (IVZ), Janus Capital (JNS), L-3 Communications (LLL), Life Technologies (LIFE), Lockheed Martin (LMT), Motorola (MOT), Raytheon (RTN), Rockwell Collins (ROK), Textron (TXT), The Estee Lauder Companies (EL), Timer Warner Cable (TWC), Xcel Energy (XEL), and Zimmer Holdings (ZMH). :theflyonthewall.com